THE US FDA has approved
Prolia, a new injectable treatment
for postmenopausal women with
osteoporosis at high fracture risk.
Prolia (denosumab) is a sixmonthly
fully human monoclonal
antibody injection which works to
decrease the destruction of bone
and lift bone mass and strength.The above article was sent to subscribers in Pharmacy Daily's issue from 04 Jun 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Jun 10
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.